Infection-induced Myeloperoxidase Specific Antineutrophil Cytoplasmic Antibody (MPO-ANCA) Associated Vasculitis: A Systematic Review
Overview
Affiliations
Background: We conducted a systematic review to identify cases of infection-induced anti-myeloperoxidase (MPO) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Methods: PubMed/Medline databases were searched from inception to July of 2020, according to PRISMA guidelines.
Results: Among the 618 abstracts identified, 18 articles describing 23 patients (60.9% female, mean age 50.5 years) were included. Median time between infection and vasculitis development was 3 months. Five (21.7%) patients expired during follow-up. Vasculitis regressed after the resolution of infection in 12/23 (52.2%). ANCA titers decreased significantly on follow-up in 14/16 patients and in all survivors in which they were measured. Pathogens reported included Mycobacterium spp., Coccidioides spp., Rickettsia rickettsii, Staphylococcus spp., EBV, CMV and Dengue virus.
Conclusions: MPO-AAV can occur after infection and may regress after its resolution. Infection should be considered in cases of MPO-AAV, as immunosuppressive treatment can have catastrophic results if the infection is not adequately treated.
Mizuhashi K AME Case Rep. 2025; 9:8.
PMID: 39866275 PMC: 11760511. DOI: 10.21037/acr-24-112.
Li H, Yu J, Zeng Z, Liu C, Zhang Y, Xia H BMC Infect Dis. 2024; 24(1):1150.
PMID: 39396943 PMC: 11472509. DOI: 10.1186/s12879-024-10035-6.
Autoimmune Diseases Following Environmental Disasters: A Narrative Review of the Literature.
Mpakosi A, Cholevas V, Tzouvelekis I, Passos I, Kaliouli-Antonopoulou C, Mironidou-Tzouveleki M Healthcare (Basel). 2024; 12(17).
PMID: 39273791 PMC: 11395540. DOI: 10.3390/healthcare12171767.
Becker R, Tantry U, Khan M, Gurbel P J Thromb Thrombolysis. 2024; 58(1):15-49.
PMID: 39179952 PMC: 11762605. DOI: 10.1007/s11239-024-03028-4.
Antineutrophil cytoplasmic antibody positivity incidence before and during COVID-19 pandemic.
Dijana P, Marin P, Simac P, Ana V, Katarina B, Katarina G Rheumatol Int. 2024; 44(10):1935-1940.
PMID: 38656608 DOI: 10.1007/s00296-024-05596-3.